Evaluation of Immunomodulatory Activities of the Heat-Killed Probiotic Strain Lactobacillus casei IMAU60214 on Macrophages In Vitro
2020
Luz María Rocha-Ramírez | Beatriz Hernández-Ochoa | Saúl Gómez-Manzo | Jaime Marcial-Quino | Noemí Cárdenas-Rodríguez | Sara Centeno-Leija | Mariano García-Garibay
Most Lactobacillus species have beneficial immunological (&ldquo:immunoprobiotic&rdquo:) effects in the host. However, it is unclear how probiotic bacteria regulate immune responses. The present study investigated the effects of heat-killed Lactobacillus casei IMAU60214 on the activity of human monocyte-derived macrophages (MDMs). Human MDMs were treated with heat-killed L. casei at a ratio (bacteria/MDM) of 50:1, 100:1, 250:1, and 500:1, and then evaluated for the following: NO production, by Griess reaction: phagocytosis of FITC-labeled Staphylococcus aureus particles: cytokine secretion profile (tumor necrosis factor (TNF)-&alpha:, interleukin (IL)-1&beta:, IL-6, IL-12p70, IL-10, and transforming growth factor (TGF)-&beta:) by ELISA: and costimulatory molecule (CD80 and CD86) surface expression, by flow cytometry. Heat-killed L. casei IMAU60214 enhanced phagocytosis, NO production, cytokine release, and surface expression of CD80 and CD86 in a dose-dependent manner. All products were previously suppressed by pretreatment with a Toll-like receptor 2 (TLR2)-neutralizing antibody. Overall, our findings suggest that this probiotic strain promotes an M1-like pro-inflammatory phenotype through the TLR2 signaling pathway. These effects on macrophage phenotype help explain the probiotic efficacy of Lactobacillus and provide important information for the selection of therapeutic targets and treatments compatible with the immunological characteristics of this probiotic strain.
显示更多 [+] 显示较少 [-]